Prices on some 2,500 drugs will fall in Switzerland on June 1 as the country begins using reference pricing. Drugmakers agreed to drop legal challenges to reference pricing, and the government agreed to speed drug approvals. The agreement will be up for renegotiation at the end of 2014.

Full Story:
PharmaTimes (U.K.)

Related Summaries